Articles
29 May 2009
Vol. 1 No. 5: International Symposium on Infection-Driven Lymphomas, Rome, April 17-19, 2005
https://doi.org/10.4081/hmr.v1i5.248

Pathology of Epstein-Barr virus-related lymphomas in HIV

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
676
Views
732
Downloads

Authors

Luigi Maria Larocca
support@pagepress.org
Acquired immunodeficiency syndrome-related non-Hodgkin lymphomas (AIDS-NHL) represent a significant source of morbidity and mortality among HIV-infected individuals.1 According to body location and histologic criteria, the pathologic spectrum of AIDS-NHL includes systemic AIDS-NHL, primary central nervous system lymphoma (AIDS-PCNSL), plasmablastic lymphoma of the oral cavity (AIDS-PBL) and primary effusion lymphoma (AIDS-PEL).2 Systemic AIDS-NHL are histologically classified into AIDS-related Burkitt lymphoma (AIDS-BL) and AIDS-related diffuse large B-cell lymphoma (AIDS-DLBCL). All AIDS-PCNSL are histologically represented by DLBCL. Despite their clinico-pathologic heterogeneity, most AIDS-NHL derive from B-cells that have experienced the germinal center (GC) reaction3 and, therefore, have been exposed to the mechanism of somatic hypermutation (SHM) which normally targets the immunoglobulin variable region (IgV).

Altmetrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite



Pathology of Epstein-Barr virus-related lymphomas in HIV. (2009). Hematology Meeting Reports (formerly Haematologica Reports), 1(5). https://doi.org/10.4081/hmr.v1i5.248